QTI Share Price Performance
US$2.60
-4.60 (-63.89%)
77.6% undervalued intrinsic discount
US$11.60
Fair Value
Price US$2.60
AnalystConsensusTarget US$11.60
AnalystHighTarget US$13.20
AnalystLowTarget US$10.00
Fair ValueUS$11.60
Share Pricen/a
QT Imaging Holdings, Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 14 Fair Values set on narratives written by author
QTI Community Narratives
AN
Fair Value
·Fair Value US$11.6 77.6% undervalued intrinsic discount
Radiation Free Breast Imaging And Regulatory Momentum Will Support Long Term Screening Adoption
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value
·Fair Value US$13.2 80.3% undervalued intrinsic discount
Radiation Free Breast Imaging And Regulatory Progress Will Support Powerful Long Term Upside
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value US$10 74.0% undervalued intrinsic discount
Slow Reimbursement And Costly SaaS Shift Will Ultimately Support Radiation Free Breast Imaging Adoption
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
QT Imaging Holdings
80.3% undervalued intrinsic discount
Radiation Free Breast Imaging And Regulatory Progress Will Support Powerful Long Term Upside
View narrativeAN
Published 4 May
QT Imaging Holdings
77.6% undervalued intrinsic discount
Radiation Free Breast Imaging And Regulatory Momentum Will Support Long Term Screening Adoption
View narrativeAN
Published 17 Apr
QT Imaging Holdings
74.0% undervalued intrinsic discount
Slow Reimbursement And Costly SaaS Shift Will Ultimately Support Radiation Free Breast Imaging Adoption
View narrativeAN
Published 2 Apr
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
Radiation Free Breast Imaging And Regulatory Progress Will Support Powerful Long Term Upside
Fair Value: US$13.2 80.3% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Radiation Free Breast Imaging And Regulatory Momentum Will Support Long Term Screening Adoption
Fair Value: US$11.6 77.6% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Slow Reimbursement And Costly SaaS Shift Will Ultimately Support Radiation Free Breast Imaging Adoption
Fair Value: US$10 74.0% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
QT Imaging Holdings, Inc. Key Details
Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
- -1.40
- 40.39%
- -77.26%
- 680.9%
About QTI
- Founded
- 2012
- Employees
- 32
- CEO
- WebsiteView website
QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems with low frequency sound waves for detection, diagnosis, and treatment of diseases in the United States and Internationally. The company offers QT Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. It serves patients, medical professionals, and radiologists. The company has a collaboration with Olea Medical S.A.S for the development of QTI Imaging-Olea Viewer; and a strategic partnership with Intelerad Medical Systems Incorporated. QT Imaging Holdings, Inc. was founded in 2012 and is headquartered in Novato, California.
